Atlas Trials

Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation

Clinical trial NCT01607879 · COMPLETED

Trial details

NCT number
NCT01607879
Sponsor
Medical College of Wisconsin
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2014-03-01
Primary completion
2018-07-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.